COMPARED EFFECTIVENESS, SAFETY AND COST OF DEXMEDETOMIDINE WITH MIDAZOLAM: A REVIEW
##plugins.themes.EpsilonTheme.article.main##
Nila Rusdi Rahayu*
Siti Mutripah
Dexmedetomidine, an alpha 2 receptor agonist sedative drug, has recently garnered attention as a viable alternative to midazolam, a widely used benzodiazepine for sedation in adult patients. The aim of this study was to conduct a comprehensive comparison of the clinical sedative efficacy, cost-effectiveness, and safety profiles of dexmedetomidine versus midazolam, utilizing a randomized controlled trial design. The search encompassed several databases, including PubMed, Scopus, Web of Knowledge, CINAHL, the United States National Library of Medicine, and Google Scholar for Systematic Reviews, using the keywords 'dexmedetomidine,' 'midazolam,' and 'effectiveness.' The findings revealed that dexmedetomidine demonstrated a more favorable safety profile, with a lower incidence of delirium compared to midazolam. In terms of effectiveness, no significant differences were observed between the two drugs for local sedation. Notably, adult patients treated with dexmedetomidine had a shorter Intensive Care Unit (ICU) stay (7 days) compared to those receiving midazolam (10 days). Similarly, pediatric ICU treatment indicated a shorter duration with dexmedetomidine (20 hours) as opposed to midazolam (38 hours). Regarding cost-effectiveness, dexmedetomidine emerged as a cost-saving option, being approximately 10% cheaper than midazolam for adult ICU patients. These findings collectively highlight the advantages of dexmedetomidine over midazolam, encompassing superior safety, effectiveness, and cost-efficiency, thus providing valuable insights for healthcare practitioners and decision-makers.
Aggarwal, J., Lustrino, J., Stephens, J., Morgenstern, D., & Tang, W. Y. (2020). Cost-minimization analysis of dexmedetomidine compared to other sedatives for short-term sedation during mechanical ventilation in the United States. ClinicoEconomics and Outcomes Research, 389–397.
Azeem, T. M. A., Yosif, N. E., Alansary, A. M., Esmat, I. M., & Mohamed, A. K. (2018). Dexmedetomidine vs morphine and midazolam in the prevention and treatment of delirium after adult cardiac surgery; a randomized, double-blinded clinical trial. Saudi Journal of Anaesthesia, 12(2), 190.
Gulla, K. M., Sankar, J., Jat, K. R., Kabra, S. K., & Lodha, R. (2021). Dexmedetomidine vs midazolam for sedation in mechanically ventilated children: a randomized controlled trial. Indian Pediatrics, 58, 117–122.
Huang, Y., Deng, Y., Zhang, R., Meng, M., & Chen, D. (2022). Comparing the effect of dexmedetomidine and midazolam in patients with brain injury. Brain Sciences, 12(6), 752.
Jakob, S. M., Ruokonen, E., Grounds, R. M., Sarapohja, T., Garratt, C., Pocock, S. J., Bratty, J. R., Takala, J., & Investigators, D. for L.-T. S. (2012). Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. Jama, 307(11), 1151–1160.
Kawazoe, Y., Miyamoto, K., Morimoto, T., Yamamoto, T., Fuke, A., Hashimoto, A., Koami, H., Beppu, S., Katayama, Y., & Itoh, M. (2017). Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis: a randomized clinical trial. Jama, 317(13), 1321–1328.
Kim, J.-Y., Park, S.-Y., Han, Y.-S., & Lee, H. (2022). Comparison of vital sign stability and cost effectiveness between midazolam and dexmedetomidine during third molar extraction under intravenous sedation. Journal of the Korean Association of Oral and Maxillofacial Surgeons, 48(6), 348–355.
Kim, J., Choi, S. M., Park, Y. S., Lee, C.-H., Lee, S.-M., Yoo, C.-G., Kim, Y. W., & Lee, J. (2021). Dexmedetomidine versus midazolam for sedation during endobronchial ultrasound-guided transbronchial needle aspiration: a randomised controlled trial. European Journal of Anaesthesiology| EJA, 38(5), 534–540.
Lachaine, J., & Beauchemin, C. (2012). Economic evaluation of dexmedetomidine relative to midazolam for sedation in the intensive care unit. The Canadian Journal of Hospital Pharmacy, 65(2), 103.
Li, B. L., Luo, H., Huang, J. X., Zhang, H. H., Paquin, J. R., Yuen, V. M., & Song, X. R. (2022). Using intranasal dexmedetomidine with buccal midazolam for magnetic resonance imaging sedation in children: A single-arm prospective interventional study. Frontiers in Pediatrics, 10, 889369.
Mahmoud, M., & Mason, K. P. (2015). Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. British Journal of Anaesthesia, 115(2), 171–182.
Moore, J. P. R., Shehabi, Y., Reade, M. C., Bailey, M., Fraser, J. F., Murray, L., Anstey, C., & Singer, M. (2022). Stress response during early sedation with dexmedetomidine compared with usual-care in ventilated critically ill patients. Critical Care, 26(1), 1–10.
Panda, S., Pujara, J., Chauhan, A., Varma, A., Pandya, H., & Patel, S. (2021). Comparative study of intranasal dexmedetomidine v/s midazolam for sedation of pediatric patients during transthoracic echocardiography. Annals of Cardiac Anaesthesia, 24(2), 224.
Salem, K., Khoshrang, H., Esmaeeli, E., & Vatankhah, M. (2022). Comparison of two intranasal sedatives, midazolam versus Dexmedetomidine, in children with high dental fear: A randomized clinical trial. Journal of Dentistry, 23(2), 129.
Vuković, I., Duplančić, B., Benzon, B., Đogaš, Z., Kovač, R., & Pecotić, R. (2022). Midazolam versus Dexmedetomidine in Patients at Risk of Obstructive Sleep Apnea during Urology Procedures: A Randomized Controlled Trial. Journal of Clinical Medicine, 11(19), 5849.
Wang, L., Zhang, T., Huang, L., & Peng, W. (2020). Comparison between dexmedetomidine and midazolam for sedation in patients with intubation after oral and maxillofacial surgery. BioMed Research International, 2020, 1–6.
Zhou, W.-J., Liu, M., & Fan, X.-P. (2021). Differences in efficacy and safety of midazolam vs. dexmedetomidine in critically ill patients: A meta‑analysis of randomized controlled trial. Experimental and Therapeutic Medicine, 21(2), 1.
Zhou, Y., Yang, J., Wang, B., Wang, P., Wang, Z., Yang, Y., Liang, G., Jing, X., Jin, X., & Zhang, Z. (2022). Sequential use of midazolam and dexmedetomidine for long-term sedation may reduce weaning time in selected critically ill, mechanically ventilated patients: a randomized controlled study. Critical Care, 26(1), 122.
